Identifying the Best Candidates for Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography as the Primary Staging Approach Among Men with High-risk Prostate Cancer and Negative Conventional Imaging.

Saved in:
Bibliographic Details
Title: Identifying the Best Candidates for Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography as the Primary Staging Approach Among Men with High-risk Prostate Cancer and Negative Conventional Imaging.
Authors: Ma TM; Department of Radiation Oncology, UCLA Medical Center, Los Angeles, CA, USA., Gafita A; Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, UCLA Medical Center, Los Angeles, CA, USA., Shabsovich D; Department of Radiation Oncology, UCLA Medical Center, Los Angeles, CA, USA., Juarez J; Department of Radiation Oncology, UCLA Medical Center, Los Angeles, CA, USA., Grogan TR; Statistics Core, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA., Thin P; Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, UCLA Medical Center, Los Angeles, CA, USA., Armstrong W; Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, UCLA Medical Center, Los Angeles, CA, USA., Sonni I; Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, UCLA Medical Center, Los Angeles, CA, USA., Nguyen K; Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, UCLA Medical Center, Los Angeles, CA, USA., Lok V; Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, UCLA Medical Center, Los Angeles, CA, USA., Reiter RE; Department of Urology, UCLA Medical Center, Los Angeles, CA, USA., Rettig MB; Department of Urology, UCLA Medical Center, Los Angeles, CA, USA; Department of Medicine, Division of Hematology-Oncology, UCLA Medical Center, Los Angeles, CA, USA., Steinberg ML; Department of Radiation Oncology, UCLA Medical Center, Los Angeles, CA, USA., Kupelian PA; Department of Radiation Oncology, UCLA Medical Center, Los Angeles, CA, USA., Yang DD; Harvard Radiation Oncology Program, Harvard Medical School, Boston, MA, USA., Muralidhar V; Harvard Radiation Oncology Program, Harvard Medical School, Boston, MA, USA., Chu C; Department of Urology, UCSF Medical Center, San Francisco, CA, USA., Feng F; Department of Urology, UCSF Medical Center, San Francisco, CA, USA; Department of Radiation Oncology, UCSF Medical Center, San Francisco, CA, USA., Savjani R; Department of Radiation Oncology, UCLA Medical Center, Los Angeles, CA, USA., Deng J; Department of Radiation Oncology, UCLA Medical Center, Los Angeles, CA, USA., Parikh NR; Department of Radiation Oncology, UCLA Medical Center, Los Angeles, CA, USA., Nickols NG; Department of Radiation Oncology, UCLA Medical Center, Los Angeles, CA, USA., Elashoff D; Statistics Core, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA., Czernin J; Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, UCLA Medical Center, Los Angeles, CA, USA., Calais J; Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, UCLA Medical Center, Los Angeles, CA, USA., Kishan AU; Department of Radiation Oncology, UCLA Medical Center, Los Angeles, CA, USA. Electronic address: aukishan@mednet.ucla.edu.
Source: European urology oncology [Eur Urol Oncol] 2022 Feb; Vol. 5 (1), pp. 100-103. Date of Electronic Publication: 2021 Feb 16.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101724904 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2588-9311 (Electronic) Linking ISSN: 25889311 NLM ISO Abbreviation: Eur Urol Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2588-9311
DOI:10.1016/j.euo.2021.01.006